Search results for "Pathophysiology of hypertension"

showing 10 items of 15 documents

THE METABOLIC SYNDROME IN HYPERTENSION

2019

The metabolic syndrome (MS) is currently considered to be a cluster of metabolic and cardiovascular risk factors including blood pressure elevation. A higher risk to develop hypertension in MS subjects with high-normal blood pressure has been observed and, when hypertension is established, seems to be what confers a higher cardiovascular risk on top of the risk induced by blood pressure elevation. Therefore, assessment of MS components can result in clinical utility strategy to manage hypertension based on individual risk. The main mechanisms for blood pressure elevation include overactivity of the sympathetic and the reninangiotensin system, abnormal renal sodium handling, and endothelial …

medicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedicine.diseaseInsulin resistanceBlood pressureEndocrinologyInternal medicineDiabetes mellitusPathophysiology of hypertensionAortic pressureCardiologyMedicineEndothelial dysfunctionMetabolic syndromebusinessLipid profile
researchProduct

Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension

2017

Multicellular interactions of platelets, leukocytes, and the blood vessel wall support coagulation and precipitate arterial and venous thrombosis. High levels of angiotensin II cause arterial hypertension by a complex vascular inflammatory pathway that requires leukocyte recruitment and reactive oxygen species production and is followed by vascular dysfunction. We delineate a previously undescribed, proinflammatory coagulation-vascular circuit that is a major regulator of vascular tone, blood pressure, and endothelial function. In mice with angiotensin II-induced hypertension, tissue factor was up-regulated, as was thrombin-dependent endothelial cell vascular cellular adhesion molecule 1 ex…

Blood PlateletsMale0301 basic medicinemedicine.medical_specialtyMacrophage-1 AntigenVascular Cell Adhesion Molecule-1Blood Pressure030204 cardiovascular system & hematologyThromboplastinMice03 medical and health sciencesTissue factor0302 clinical medicineThrombinInternal medicinemedicineAnimalsHumansPlateletRats WistarEndothelial dysfunctionBlood CoagulationFactor XIAgedMice Knockoutbusiness.industryAngiotensin IIThrombinGeneral MedicineMiddle AgedOligonucleotides Antisensemedicine.diseaseAngiotensin IIMice Inbred C57BL030104 developmental biologyEndocrinologyBlood pressuremedicine.anatomical_structurePlatelet Glycoprotein GPIb-IX ComplexPathophysiology of hypertensionHypertensionFemalebusinessmedicine.drugBlood vesselScience Translational Medicine
researchProduct

Oxidative Stress, Inflammation and Endothelial Biomarkers in Arterial Hypertension

2008

business.industryPathophysiology of hypertensionImmunologyInternal MedicineMedicineInflammationmedicine.symptombusinessmedicine.diseasemedicine.disease_causeOxidative stressCurrent Hypertension Reviews
researchProduct

Relationship between endothelin and insulin-like growth factor-1 in essential hypertension.

1999

medicine.hormonemedicine.medical_specialtybusiness.industrymedicine.medical_treatmentEssential hypertensionmedicine.diseaseEndothelinsInsulin-like growth factorEndocrinologyInternal medicinePathophysiology of hypertensionInternal MedicinemedicineEndothelin receptorbusinessAmerican Journal of Hypertension
researchProduct

Experiences with Blockade of the Renin System in Human Hypertension Using Converting Enzyme Inhibitor SQ 20,881 and Saralasin

1980

The development of agents which are capable of producing in vivo angiotensin II blockade has provided to investigators and clinicians alike the opportunity to determine and to quantify the extent to which the renin-angiotensin system participates in the maintenance of hypertensive states. High levels of plasma renin activity relative to the state of sodium balance have been documented in patients with malignant, surgically remediable renovascular hypertension and also in some patients with essential hypertension.1 The recent development of the angiotensin II analogue sar1-ala8-angiotensin II (saralasin) provided evidence to support the concept that these elevated renin levels are in fact pa…

medicine.medical_specialtyAngiotensin II receptor type 1business.industryPharmacologymedicine.diseaseAngiotensin IIPlasma renin activityBlockadeRenovascular hypertensionchemistry.chemical_compoundEndocrinologychemistryPathophysiology of hypertensionInternal medicineRenin–angiotensin systemMedicinebusinessSaralasin
researchProduct

Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease

2016

AbstractWe have reviewed the effects of angiotensin II type 1 receptor antagonists (ARBs) in various animal models of hypertension, atherosclerosis, cardiac function, hypertrophy and fibrosis, glucose and lipid metabolism, and renal function and morphology. Those of azilsartan and telmisartan have been included comprehensively whereas those of other ARBs have been included systematically but without intention of completeness. ARBs as a class lower blood pressure in established hypertension and prevent hypertension development in all applicable animal models except those with a markedly suppressed renin–angiotensin system; blood pressure lowering even persists for a considerable time after d…

0301 basic medicineBlood Pressure030204 cardiovascular system & hematologyKidneyurologic and male genital diseasesBenzoatesAnimals Genetically ModifiedRenin-Angiotensin SystemGene Knockout Techniques0302 clinical medicineAzilsartanPharmacology (medical)TelmisartanOxadiazolesKidneybiologyStrokemedicine.anatomical_structureCardiovascular DiseasesHypertensionDrug Therapy Combinationmedicine.drugmedicine.medical_specialty03 medical and health sciencesMetabolic DiseasesCulture TechniquesInternal medicineRenin–angiotensin systemmedicineAnimalsHumansAntihypertensive AgentsPharmacologyAngiotensin II receptor type 1business.industryAngiotensin-converting enzymeAtherosclerosisLipid Metabolismmedicine.diseaseDisease Models AnimalGlucose030104 developmental biologyBlood pressureEndocrinologyPathophysiology of hypertensionbiology.proteinBenzimidazolesEndothelium VascularTelmisartanbusinessAngiotensin II Type 1 Receptor BlockersPharmacology & Therapeutics
researchProduct

Markers of endothelial activation and left ventricular hypertrophy in essential hypertension

2003

Endothelial activationmedicine.medical_specialtybusiness.industryInternal medicinePathophysiology of hypertensionInternal MedicinemedicineCardiologymedicine.diseasebusinessLeft ventricular hypertrophyEssential hypertensionAmerican Journal of Hypertension
researchProduct

Hemorheological abnormalities in human arterial hypertension

2014

Blood rheology is impaired in hypertensive patients. The alteration involves blood and plasma viscosity, and the erythrocyte behaviour is often abnormal. The hemorheological pattern appears to be related to some pathophysiological mechanisms of hypertension and to organ damage, in particular left ventricular hypertrophy and myocardial ischemia. Abnormalities have been observed in erythrocyte membrane fluidity, explored by fluorescence spectroscopy and electron spin resonance. This may be relevant for red cell flow in microvessels and oxygen delivery to tissues. Although blood viscosity is not a direct target of antihypertensive therapy, the rheological properties of blood play a role in the…

erythrocyte deformabilitymedicine.medical_specialtySettore MED/09 - Medicina InternaRed Cellbusiness.industryerythrocyte membraneBlood viscosityessential hypertensionessential hypertension blood viscosity erythrocyte deformabilityCondensed Matter PhysicsEssential hypertensionmedicine.diseaseLeft ventricular hypertrophyPathophysiologyErythrocyte membraneInternal medicinePathophysiology of hypertensionblood viscositymedicineCardiologyErythrocyte deformabilityGeneral Materials SciencebusinessKorea-Australia Rheology Journal
researchProduct

Orthostatism modifies insulin-like growth factor 1 and insulin plasma levels in essential hypertension.

1999

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentInsulinPlasma levelsmedicine.diseaseEssential hypertensionInsulin-like growth factorEndocrinologyInternal medicinePathophysiology of hypertensionInternal MedicinemedicinebusinessAmerican Journal of Hypertension
researchProduct

Reconstitution of Myelomonocyte-Depleted Mice With Monocytes, But Not With Neutrophils, Reestablishes Arterial Hypertension and Oxidative Stress in R…

2011

0303 health sciencesmedicine.medical_specialty030309 nutrition & dieteticsbusiness.industry030302 biochemistry & molecular biologymedicine.disease_causemedicine.diseaseBiochemistry03 medical and health sciencesEndocrinologyPhysiology (medical)Pathophysiology of hypertensionInternal medicinemedicinebusinessMyelomonocyteOxidative stressFree Radical Biology and Medicine
researchProduct